SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: May 11, 1994
Seafield Capital Corporation
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Missouri 0-16946 43-1039532
-----------------------------------------------------------------
(State of other (Commission File Number) (IRS Employer
jurisdiction of Identification
incorporation) Number)
2600 Grand Ave. Suite 500
P. O. Box 410949
Kansas City, MO 64141
-----------------------------------------------------------------
(Address of principal executive offices) (Zip code)
(816) 842-7000
-----------------------------------------------------------------
(Registrant's telephone number, including area code)
Item 5. Other Events
On May 9, 1994, Seafield Capital Corporation (Seafield) issued a news release
announcing that LabOne, Inc. (LabOne), Seafield's 82% owned subsidiary, has
signed an agreement with PCS Health Systems, a subsidiary of McKesson, Inc.,
to market an integrated and fully managed system of laboratory testing and
administration services for payors and health plans throughout the U.S.
PCS and LabOne are developing a managed lab program to offer participants,
both payors and patients, substantial cost savings for clinical laboratory
testing services. This program, modeled after PCS' managed pharmaceutical
services, is designed to reduce benefit costs for participating health plans.
The program will utilize a point-of-service card identification system. PCS
currently manages prescription-drug benefit programs for over 45 million
people. LabOne currently performs testing on over three million specimens
annually.
Bert H. Hood, chairman, president and chief executive officer of LabOne, said,
"This new affiliation will give LabOne an outstanding opportunity to join
forces with PCS in marketing our higher-quality, lower-cost laboratory testing
program to insurers, Blue Cross and Blue Shield systems, managed care
organizations, large employers, and other payors of medical benefits."
LabOne markets and operates a centralized laboratory with two divisions
serving the laboratory testing industry -- Center for Laboratory Services
(CLS), the clinical testing division, and Home Office Reference Laboratory
(HORL), the insurance testing division.
On May 10, 1994, Seafield issued a news release announcing that Response
Technologies, Inc. (Response), Seafield's 59% owned subsidiary, has signed a
provider contract with U.S. Healthcare of Blue Bell, Pennsylvania. U.S.
Healthcare is a HMO with over 1.6 million members in eight states and
Washington, D.C. This agreement allows all IMPACT(registered trademark)
Centers to deliver high-dose chemotherapy with peripheral blood stem cell
(PBSC) support and other advanced cancer treatments.
Response owns and operates a network of specialized out-patient treatment
centers, or IMPACT(registered trademark) Centers, which provide advanced
cancer treatment services under the direction of practicing oncologists.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized officer.
Seafield Capital Corporation
Date: May 11, 1994 By: /s/ Steven K. Fitzwater
---------------------------
Steven K. Fitzwater
Vice President, Chief Accounting
Officer and Secretary
